↓ Skip to main content

Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study

Overview of attention for article published in Advances in Therapy, January 2019
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
41 Mendeley
Title
Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
Published in
Advances in Therapy, January 2019
DOI 10.1007/s12325-018-0863-1
Pubmed ID
Authors

Hidenobu Tanihara, Takahiko Kakuda, Tetsuro Sano, Takashi Kanno, Ryosuke Imada, Wataru Shingaki, Ryoji Gunji

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 15%
Student > Master 6 15%
Researcher 6 15%
Other 3 7%
Student > Ph. D. Student 2 5%
Other 4 10%
Unknown 14 34%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Immunology and Microbiology 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Environmental Science 2 5%
Agricultural and Biological Sciences 2 5%
Other 4 10%
Unknown 15 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2019.
All research outputs
#18,661,637
of 23,120,280 outputs
Outputs from Advances in Therapy
#1,672
of 2,385 outputs
Outputs of similar age
#324,863
of 437,326 outputs
Outputs of similar age from Advances in Therapy
#48
of 56 outputs
Altmetric has tracked 23,120,280 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,385 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,326 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.